Menu Icon Search
Close Search

MRSA: What Health Care Providers Should Know

Created November 28, 2007 by Alison Hayward, MD
Share Comment


In the battle of humans vs. bacteria, a new enemy has emerged as the most feared “superbug” of 2007. Forget West Nile and bird flu – Methicillin Resistant Staphylococcus Aureus (MRSA) is suddenly all over the media. It is an overdue and well-deserved spot in the limelight.

MRSA rose to prominence last month when a CDC report published in JAMA estimated that nearly 19,000 people had died of MRSA infections in 2005. Compare that with AIDS, which killed about 17,000 in the same year, and it becomes readily apparent that most of the country is unaware of the degree of threat posed by MRSA. In fact, many people still do not know what MRSA is.

Here is a quick primer on MRSA to help answer any questions your patients, friends, and family may have.

What is MRSA?

Most healthcare professionals know that culture results which return as “Gram positive cocci in clusters” are an ominous code for Staph aureus. Its name means ‘golden clusters of seeds,’ which describes not only its microscopic appearance, but also its golden sheen when grown on a blood agar plate.

Staphylococcus aureus is a bacterium that was discovered in 1880 in surgical abscesses. Staph has a talent for antibiotic resistance, and it became resistant to penicillin nearly immediately after penicillin was introduced in the 1940s. Methicillin is an antibiotic that was used to treat this penicillin-resistant staph, but as the bug continued to collect resistances, MRSA was born.

MRSA is a strain of staph that was identified in 1961. MRSA is by no means a new bacteria, it is only new to the public consciousness. Due to the mathematics of infectious disease, MRSA has exploded along an exponential curve and now represents the majority of all staph infections seen in ICUs and in the ED.

Is MRSA really a “superbug”?

MRSA is potentially lethal, as is its parent, the pan-sensitive Staph aureus, often via bloodstream infections or bacteremia that leads to sepsis and ultimately to septic shock. However, MRSA is not deemed a superbug simply due to its resistance. It also has increased morbidity due to the accumulation of toxin genes via bacteriophages, such as Panton-Valentine leukocidin (PVL). A bacteriophage is basically a virus containing a snippet of DNA that can spread through a population of bacteria, similarly to the way a bacterial infection spreads through a human population. PVL is called a ‘leukocidin’ because it has the ability to burst white blood cells (leukocytes).

MRSA may be fearsome in its rapidity and pure purulence, but it is not invincible by any means. Most medical students know that MRSA can be treated empirically with vancomycin, a “big gun” antibiotic. However, many may not be aware that MRSA is also often susceptible to such “small guns” as doxycycline or trimethoprim/sulfamethoxazole. As with any infectious disease, the best strategy is to start broad coverage antibiotics immediately with any suspicion of MRSA infection, and then to narrow coverage based on culture and sensitivity results. A CA-MRSA abscess, the most common manifestation that a normal, immunocompetent member of the community might face, can still be treated with a simple incision and drainage (I&D) of the wound. CDC recommendations suggest not adding antibiotic coverage unless the patient is immunocompromised, has severe local symptoms or signs of systemic infection, or does not respond to I&D. Antibiotic choices for outpatient treatment of MRSA skin infection include clindamycin and doxycycline.

Friends, family, and patients who are concerned about the danger of MRSA should be congratulated on their awareness of public health issues, then reassured with the following facts:

  • Colonization with MRSA does not equal infection. Many people (an estimated 2 million in the U.S.) carry MRSA with no symptoms at all.
  • MRSA infection is treatable with proper antibiotics, and does not always require antibiotics.
  • Simple prevention strategies can greatly reduce the likelihood of a MRSA infection, particularly a severe one.

Who’s at fault for the spread of MRSA?

One of the controversial aspects of the rise in MRSA infections is whether doctors or patients are to blame. Doctors point their fingers at patients who demand antibiotics regardless of whether they are indicated, and patients likewise are concerned that doctors have been reckless with their prescriptions.

According to Jessica Snyder Sachs, the author of “Good Germs, Bad Germs,” one of the big misconceptions that physicians have had about MRSA is “that it’s just a hospital bug. We have for years had patients dying of MRSA from the community.” Snyder Sachs points out that up until recently, physicians simply did not consider the diagnosis of MRSA unless patients had some exposure to a healthcare scenario such as a nursing home or a hospital. Invasive infections that are most dangerous are certainly far more likely in those who have these exposures, but in order to select appropriate antibiotics to prevent non-invasive infections from becoming invasive, MRSA must be considered in those with no risk factors at all.

Of course, the other side of the coin is that patients must be educated as to why antibiotics should not be used unless necessary. Patient ‘ordering’ of antibiotics in the manner of ordering a meal at a fast food joint has been lampooned by physicians, but as any drug-seeker knows, it takes more than one person to obtain a prescription medication. Consider whether antibiotics are necessary before prescribing, and consider discontinuing antibiotic therapy if cultures are negative or if coverage can be narrowed.

What is the difference between CA-MRSA and HA- MRSA?

Community Acquired (CA)-MRSA and Hospital Acquired (HA)-MRSA have historically been significantly different bacteria. HA-MRSA strains tend to have accumulated resistance to more antibiotics, but CA-MRSA is actually more toxic. CA-MRSA can replicate more rapidly and is more often associated with PVL toxin, presumed to be a key factor in how CA-MRSA infections notoriously produce necrotic lesions such as abscesses or hemorrhagic pneumonia. New studies have shown that CA-MRSA can basically pulverize white cells, with or without PVL toxin, and that makes CA-MRSA hard for our bodies to defend against despite the fact that it is not resistant to as many antibiotics as its hospital-acquired cousin. There are several of these highly virulent strains of CA-MRSA that are now wreaking havoc in the community, the most famous of which is the USA300 strain.

What are the best ways to prevent MRSA infections?

MRSA is spread mainly by direct and indirect contact with human hands – transmission by droplet/airborne routes is uncommon. Simple things like handwashing and use of gloves and gowns are still the best ways to prevent the spread of infections. For your patients, the most important things are not only to wash hands, but also to keep cuts and abrasions clean, dry, and covered. As many have noted, regular maintenance of hygiene in high-risk areas, such as locker rooms, is key. “What we don’t want is a one-time massive cleaning after a student has a case of MRSA.” Jessica Snyder Sachs points out, referring to the recent media blitz regarding MRSA infections in schoolchildren. “I also think that this is an opportunity to educate people about MRSA pneumonia that is community-acquired and tends to come on the heels of the flu” — another great reason to be sure that you and your patients get the flu shot annually.

What are some system-related ways to combat the spread of MRSA?

“We desperately, definitely need more antibiotics in the short term, because we are running out of them,” states Jessica Snyder Sachs. “In the long term, we need other solutions. The bacteria can evolve around antibiotics too quickly.” As examples of these future solutions, she notes that not only is there a MRSA vaccine in development, but also scientists are considering how we can detoxify MRSA. After all, many people are colonized with MRSA and do not have any manifestation of infection. What if we could leave the MRSA in place, but turn off the toxins? Or what if we could use our body’s ability to host friendly bacteria to create a hostile environment for MRSA?

In the past, mild forms of staph have been used in an attempt to displace virulent staph, or to prevent the virulent staph from colonizing in the first place. These are some of the exciting antibiotic-free ideas that we may see in the future. For now, making a habit of regular handwashing and good hygiene, particularly in the hospital, is the best way to fight MRSA. Any systematic change that helps to facilitate or ingrain a “culture of handwashing” (not to mention stethoscope-washing) will help. Reassure your patients that using regular soap, alcohol-based foams or hand sanitizers are all good ways to prevent MRSA that do not encourage further resistance. The use of cleansers that contain antibiotic ingredients like triclosan is unnecessary and should be discouraged.

This is not the first time that resistant strains of staph aureus have emerged and caused deadly infection. A prior pandemic of resistant staph called ‘phage type 80/81’ caused the deaths of many mothers and babies from sepsis in the 1950s and 1960s. Studies have shown that CA-MRSA causing infections now is directly related to this killer staph from the past. In infectious disease, the adage that “history repeats itself” is as true as ever. Will the cycle continue? Unless we start fighting staph infections with smarter plans instead of with ever-bigger “guns”, the answer is most certainly yes.

1) Klevens, et al. Invasive Methicillin-Resistant Staphylococcus aureus Infections in the United States. JAMA, 2007;298:1763-1771.
2) Staphylococcus Aureus. Wikipedia. Found on 11/15/07
3) Methicillin Resistant Staphylococcus Aureus. Wikipedia. Found on 11/15/07.
4) Drug-resistant Staph Infections on the Rise, Study Finds. PBS Online NewsHour, 10/17/2007. Found on 11/15/07 at…aph_10-17.html
5) MRSA: Information for Patients. CDC Website. Found on 11/15/07.
6) Wang, et al. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nature Medicine, 2007 Nov 11.
7) Strategies for Clinical Management of MRSA in the Community. March 2006 – CDC Summary. Found on 11/15/07 at…Strategies.pdf
8) Robinson, et al. Re-emergence of early pandemic Staphylococcus aureus as a community-acquired meticillin-resistant clone. The Lancet, 2005;365,1256-1258.


// Share //

// Comments //


  1. AK says:

    Greetings from Sweden! This article is well needed since many physicians lack even the basic knowledge about the caracteristics, pathogenesis and consequenses om MRSA.

  2. DD says:

    This was very interesting. As a first year osteopathic medical student, I have always wondered if using antibotic ointments and soaps was ever a good idea in the first place. And with the MRSA scare, my school is making us disinfect our tables before and after we use them.

  3. Winston Gibbs says:

    I found that this article was well written and accessible to persons like me who have no medical training. I am of the opinion that the proliferation of cleansers containing will pose serious problems for the population.

  4. As an emergency physician I have been dealing with CA-MRSA for about 2 years. Fortunately we are finding that most strains are still resistant to either doxycycline or Bactrim (Trimethiprim/sulfa)or both. I worry about what will happen when these relatively inexpensive antibiotics become ineffective.

    Unfortunately, in the emergency room setting there are obstacles to following the CDC guidelines that recommend avoiding early use of these choices in suspected cases. The most obvious is lack of reliable follow-up (you can’t be sure patients will return in a prompt manner). Another problem that one seldom sees addressed is the fact that many of these lesions have nothing to drain at the time of first presentation. Traditionally we would have held off giving antibiotics, but now we worry that we might be missing a deeper infection.

    The result is that more patients are getting the drugs that will kill the CA-MRSA, but this could spell more problems with resistance down the line.

    Meanwhile, I agree with your emphasis on hygiene, especially with putting more attention on the value of thorough hand-washing.

  5. r.erickson says:

    I am a caregiver in a home setting. My client just found out she has mrsa.Although she has had a lesian for six months or more. Ido laundry dishes bathe help w/toileting. I wear gloves for toileting butnothing else. I relize now to wear gloves and have always washed hands. How likely is it that I could catch this.I have been sick all winter w/pneumonia once and just one sickness after another. Also how can yoiu be tested? And is it expensive?

  6. V. W says:

    Please continue to update this material….I/We find it extremely interesting and important

  7. Alaa says:

    this was a very interesting article containing many simply arranged and expressed important information..
    Gr8 Job :)

  8. CA-MRSA the lowdown | mymrsa says:

    […] STUDENT-DOCTOR […]

  9. Phone Number 256*825*5172
    My Daughter has had MRSA going on for 2 years or more with places in being lanced about every other week. She been taking everything they have given her with no good coming of it. it seem to be get worst they tell her she can work from this cause other people can get it cause she has open places all the time. they said they are tring to get her in to see a infectous disease physician but with no luck. I’ve even tried calling. If you don’t have a doctor to set up the appt. they wanted even talk to you about one. What in the world are we suppose to do just watch her die??? cause it’s not getting any better. need help please she is only 30 with 2 kids

  10. Ted says:

    MRSA is becoming more agressive because doctors are getting lazier. They aren’t doing wound cultures and identifying specific strains. They just do empiric therapy hoping it will cover the staph infection, without knowing what type of staph strain it is. This leads to a patient on 4-5 different anti-biotics during this reckless guesswork. Medical professionals are the first line people to stop the spread, and instead, are often too busy to take the time to order wound culture, wait for results and treat as specified by type of strain involved.

// Recent Articles //

  • The F-Word: Your Reaction to Failure in a Lab Matters More Than You Know

  • Posted August 28, 2015 by P.H. Grey
  • There is only one guarantee in research: sometimes things fail. It doesn’t matter what your major is, how much experience you have, or whether your research is basic, applied, clinical, or translational. A research project will test your reliance, discipline, motivation, and, at times, it might make you feel like giving up. However, when your...VIEW >
  • Fifty Shades of Care: Why Doctors Need to Pay More Attention to their Kinky Patients

  • Posted August 26, 2015 by Christy Duan
  • By Christy Duan, Contributing Writer for in-Training Reposted from here with permission On Valentine’s Day weekend last year I found myself at Paddles, the local dungeon in New York City’s Chelsea neighborhood, for the first time. I was perched at the alcohol-free bar when a man politely introduced himself as a human carpet. He asked that I tread on...VIEW >
IOTW-SDN small
  • Figure 1 Image of the Week, 8/22/15

  • Posted August 22, 2015 by Figure 1
  •   Image of the Week: See an Enterotomy in Action This patient was discovered to have gallstone ileus, a rare complication of cholelithiasis which has a high rate of mortality. An unusual multi-step process must occur in order to cause this complication. View this image on Figure 1 to see the step by step removal and learn more about this disease. Additional Info: Gallstones...VIEW >
  • Five Ways to Make Your Audition Rotation in Anesthesia (or Other Specialty!) a Success

  • Posted August 21, 2015 by Dr. Jeff Steiner
  • It is that time of year again. Medical school students across the country are preparing applications for residency and pursuing audition rotations at residencies they are hoping to woo into an interview and hopefully to match into their program. Any audition rotation is a challenge. This is especially true for the anesthesia audition rotation. For medical...VIEW >
  • 20 Questions: Jennifer Luna-Repose, DVM

  • Posted August 19, 2015 by Juliet Farmer
  • Dr. Jennifer Luna-Repose, DVM, is currently practicing at Alternatives For Animals in Lafayette, Calif., where she is an associate DVM. Dr. Luna-Repose received a bachelor’s degree in biology from University of California, Santa Cruz (1999), where she graduated with highest honors. Continuing her education, she received her Doctor of Veterinary medicine from Cornell University College...VIEW >

// Forums //